The role of B cell receptor (BCR) signaling in the pathogenesis of CLL was recently recognized, based on structural restrictions of the BCR and BCR-dependent survival and growth of malignant B cells [3]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.